Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03081910
Title	Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen (MAGENTA)
Acronym	MAGENTA
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Baylor College of Medicine
Indications	mature T-cell and NK-cell lymphoma anaplastic large cell lymphoma T-cell acute lymphoblastic leukemia mycosis fungoides prolymphocytic leukemia adult T-cell leukemia/lymphoma peripheral T-cell lymphoma Sezary's disease non-Hodgkin lymphoma angioimmunoblastic T-cell lymphoma
Therapies	CD5 CAR-T cells Cyclophosphamide + Fludarabine
Age Groups:	adult \| child \| senior
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
Houston Methodist Hospital	RECRUITING	Houston	Texas	77030	United States	Details
Texas Children's Hospital	RECRUITING	Houston	Texas	77030	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field